NTUS
NASDAQ:NTUS
Natus Medical Incorporated
- Stock
Last Close
32.96
01/01 00:00
Volume Today
132.70K
Avg: 339.69K
PE Ratio
84.22
PFCF: -
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 39.22M - | 38.87M 0.90% | 44.31M 14.01% | 49.08M 10.76% | 60.56M 23.39% | 75.63M 24.89% | 75.55M 0.11% | 73.51M 2.70% | 71.70M 2.46% | |
average payables | 31.16M - | 25.57M 17.92% | 22.52M 11.96% | 21.18M 5.93% | 21.97M 3.73% | 27.02M 23.00% | 28.03M 3.72% | 25.34M 9.59% | 29.92M 18.06% | |
average receivables | 86.03M - | 82.19M 4.47% | 90.68M 10.32% | 92.86M 2.40% | 106.72M 14.93% | 126.92M 18.93% | 121.47M 4.30% | 104.51M 13.96% | 102.45M 1.98% | |
book value per share | 10.21 - | 11.20 9.64% | 12.08 7.86% | 12.86 6.46% | 12.96 0.81% | 12.03 7.16% | 12.35 2.62% | 12.25 0.81% | 12.62 2.99% | |
capex per share | -0.12 - | -0.18 47.20% | -0.16 11.58% | -0.10 34.84% | -0.12 19.35% | -0.26 106.56% | -0.16 38.57% | -0.26 61.89% | -0.11 58.09% | |
capex to depreciation | -0.29 - | -0.49 68.91% | -0.32 33.21% | -0.20 38.07% | -0.14 32.86% | -0.25 86.68% | -0.17 31.09% | -0.31 76.20% | -0.13 57.92% | |
capex to operating cash flow | -0.10 - | -0.14 34.98% | -0.14 3.84% | -0.05 66.85% | -0.21 341.18% | -0.26 25.47% | -0.09 65.63% | -0.25 181.31% | -0.06 77.38% | |
capex to revenue | -0.01 - | -0.02 49.50% | -0.01 14.04% | -0.01 35.65% | -0.01 8.73% | -0.02 98.20% | -0.01 32.97% | -0.02 92.08% | -0.01 63.08% | |
cash per share | 1.87 - | 2.11 12.96% | 2.55 20.65% | 7.63 199.16% | 2.73 64.19% | 1.70 37.67% | 1.88 10.33% | 2.45 30.20% | 2.25 8.20% | |
days of inventory on hand | 96.81 - | 103.35 6.75% | 119.52 15.65% | 123.16 3.04% | 118.80 3.54% | 128.28 7.98% | 128.03 0.20% | 138.65 8.30% | 123.78 10.72% | |
days payables outstanding | 76.50 - | 55.15 27.91% | 58.22 5.57% | 46.44 20.23% | 41.93 9.73% | 46.34 10.53% | 48.89 5.50% | 42.94 12.17% | 66.52 54.91% | |
days sales outstanding | 87.09 - | 84.40 3.10% | 96.22 14.00% | 82.81 13.94% | 92.39 11.58% | 87.34 5.46% | 85.42 2.20% | 81.78 4.27% | 86.16 5.36% | |
debt to assets | 0.28 - | 0.19 32.96% | 0.19 1.94% | 0.36 92.75% | 0.41 13.59% | 0.38 7.35% | 0.33 11.73% | 0.32 4.91% | 0.25 21.57% | |
debt to equity | 0.39 - | 0.23 40.64% | 0.23 2.38% | 0.55 144.23% | 0.68 22.86% | 0.60 11.78% | 0.50 17.55% | 0.46 7.16% | 0.33 28.66% | |
dividend yield | ||||||||||
earnings yield | 0.03 - | 0.03 15.61% | 0.02 14.72% | 0.04 54.54% | -0.02 143.26% | -0.02 24.77% | -0.01 30.74% | -0.02 75.21% | 0.02 166.77% | |
enterprise value | 656.75M - | 1.07B 62.72% | 1.47B 37.73% | 1.09B 25.94% | 1.31B 20.11% | 1.17B 10.27% | 1.10B 6.12% | 646.34M 41.40% | 734.93M 13.71% | |
enterprise value over ebitda | 14.25 - | 18.36 28.84% | 21.41 16.61% | 15.10 29.49% | 32.46 115.06% | 139.92 330.97% | 76.57 45.28% | 66.59 13.03% | 14.90 77.62% | |
ev to operating cash flow | 17.85 - | 25.36 42.08% | 39.94 57.50% | 15.00 62.45% | 66.37 342.58% | 35.58 46.39% | 18.36 48.38% | 18.77 2.23% | 11.48 38.83% | |
ev to sales | 1.91 - | 3.00 57.36% | 3.92 30.39% | 2.85 27.11% | 2.61 8.44% | 2.21 15.32% | 2.23 0.65% | 1.55 30.20% | 1.55 0.17% | |
free cash flow per share | 1.10 - | 1.16 4.79% | 0.98 15.36% | 2.13 118.12% | 0.48 77.47% | 0.74 53.74% | 1.62 119.65% | 0.77 52.63% | 1.79 133.11% | |
free cash flow yield | 0.05 - | 0.03 34.58% | 0.02 36.52% | 0.06 201.17% | 0.01 79.48% | 0.02 72.58% | 0.05 126.58% | 0.04 22.02% | 0.08 96.86% | |
graham net net | 0.55 - | 2.10 284.02% | 2.85 35.77% | 3.26 14.15% | -2.09 164.13% | -1.45 30.33% | -0.61 58.17% | 0.01 102.24% | 1.60 11,630.07% | |
graham number | 13.24 - | 16.12 21.74% | 17.85 10.75% | 19.48 9.16% | 13.48 30.81% | 13.69 1.58% | 11.37 16.99% | 11.68 2.75% | 10.54 9.76% | |
income quality | 1.61 - | 1.30 19.32% | 0.97 25.11% | 1.71 75.61% | -0.97 156.96% | -1.44 48.11% | -3.83 166.20% | -2.07 45.93% | 4.86 334.36% | |
intangibles to total assets | 0.46 - | 0.43 5.42% | 0.40 6.96% | 0.29 27.54% | 0.49 66.04% | 0.45 7.58% | 0.42 6.75% | 0.41 3.11% | 0 100% | |
interest coverage | 20.47 - | 104.68 411.52% | 151.91 45.12% | 128.51 15.40% | 1.72 98.67% | -3.62 310.73% | -3.17 12.30% | -5.52 74.20% | 12.70 329.98% | |
interest debt per share | 1.32 - | 0.01 98.95% | 0.01 21.74% | 4.33 39,657.23% | 4.89 13.12% | 3.36 31.33% | 1.77 47.36% | 1.77 0.21% | 0.40 77.54% | |
inventory turnover | 3.77 - | 3.53 6.33% | 3.05 13.53% | 2.96 2.95% | 3.07 3.66% | 2.85 7.39% | 2.85 0.20% | 2.63 7.66% | 2.95 12.01% | |
invested capital | 0.12 - | 0.34 - | 0.37 8.97% | 0.26 28.26% | 0.13 49.90% | 0.14 3.40% | 0.03 80.01% | |||
market cap | 674.84M - | 1.14B 68.22% | 1.55B 36.92% | 1.13B 27.32% | 1.24B 10.12% | 1.13B 9.42% | 1.11B 1.34% | 672.58M 39.50% | 798.99M 18.79% | |
net current asset value | 76.64M - | 135.70M 77.06% | 152.57M 12.43% | 174.16M 14.15% | 17.81M 89.78% | 46.08M 158.78% | 63.34M 37.47% | 82.40M 30.08% | 137.75M 67.17% | |
net debt to ebitda | -0.39 - | -1.14 191.33% | -1.20 4.91% | -0.55 54.36% | 1.62 395.92% | 5.73 253.60% | -0.60 110.46% | -2.70 351.22% | -1.30 51.95% | |
net income per share | 0.76 - | 1.03 35.17% | 1.17 13.70% | 1.31 11.93% | -0.62 147.49% | -0.69 11.15% | -0.47 32.86% | -0.49 6.43% | 0.39 179.06% | |
operating cash flow per share | 1.23 - | 1.34 9.05% | 1.14 14.85% | 2.24 96.56% | 0.61 72.95% | 1.00 64.63% | 1.78 78.73% | 1.03 42.45% | 1.90 85.30% | |
payables turnover | 4.77 - | 6.62 38.71% | 6.27 5.28% | 7.86 25.36% | 8.71 10.78% | 7.88 9.53% | 7.47 5.21% | 8.50 13.86% | 5.49 35.45% | |
receivables turnover | 4.19 - | 4.32 3.20% | 3.79 12.28% | 4.41 16.19% | 3.95 10.37% | 4.18 5.78% | 4.27 2.25% | 4.46 4.46% | 4.24 5.09% | |
research and ddevelopement to revenue | 0.09 - | 0.09 4.15% | 0.08 9.36% | 0.09 8.15% | 0.10 18.12% | 0.12 11.95% | 0.12 2.42% | 0.15 24.32% | 0.12 19.35% | |
return on tangible assets | 0.10 - | 0.13 33.09% | 0.13 0.51% | 0.09 30.10% | -0.06 159.99% | -0.07 17.30% | -0.04 33.62% | -0.05 7.50% | 0.02 150.09% | |
revenue per share | 11.47 - | 11.30 1.54% | 11.62 2.86% | 11.77 1.25% | 15.38 30.76% | 16.03 4.22% | 14.70 8.35% | 12.39 15.72% | 14.06 13.53% | |
roe | 0.07 - | 0.09 23.29% | 0.10 5.41% | 0.10 5.14% | -0.05 147.11% | -0.06 19.73% | -0.04 34.58% | -0.04 7.31% | 0.03 176.77% | |
roic | 0.09 - | 0.12 32.18% | 0.13 15.21% | 0.21 58.60% | -0.07 132.13% | -0.04 48.12% | -0.02 29.92% | -0.04 49.46% | 0.04 216.69% | |
sales general and administrative to revenue | 0.14 - | 0.14 1.80% | 0.12 10.93% | 0.13 8.00% | 0.15 11.51% | 0.13 12.89% | 0.12 6.91% | 0.12 1.92% | 0.11 5.69% | |
shareholders equity per share | 10.21 - | 11.20 9.64% | 12.08 7.86% | 12.86 6.46% | 12.96 0.81% | 12.03 7.16% | 12.35 2.62% | 12.25 0.81% | 12.62 2.99% | |
stock based compensation to revenue | 0.02 - | 0.02 3.55% | 0.02 8.59% | 0.02 27.51% | 0.02 20.07% | 0.03 70.35% | 0.02 47.48% | 0.02 36.44% | 0.03 29.98% | |
tangible asset value | 110.26M - | 163.64M 48.41% | 196.71M 20.21% | 227.10M 15.45% | 76.52M 66.31% | 111.35M 45.52% | 154.96M 39.17% | 167.05M 7.81% | 424.75M 154.26% | |
tangible book value per share | 3.68 - | 5.20 41.32% | 6.08 17.05% | 7.00 15.05% | 2.35 66.41% | 3.36 43.12% | 4.60 36.75% | 4.98 8.24% | 12.62 153.44% | |
working capital | 116.69M - | 148.66M 27.40% | 164.25M 10.48% | 325.86M 98.39% | 213.49M 34.48% | 152.33M 28.65% | 126.93M 16.68% | 125.95M 0.77% | 162.69M 29.17% |
All numbers in USD (except ratios and percentages)